Background: multi-morbidity is an increasing challenge in western medicine and has the potential to impact patients' quality of life, treatment options and compliance with medications. The aim of this study was to identify the early-life predictors of long-term multi-morbidity in an historical cohort, the Hertfordshire Cohort Study (HCS). Methods: perinatal and infant health records were kept on all children born in Hertfordshire between 1931 and 1939. Participants who were still alive in 1998 were recruited to the HCS and data collected on major chronic diseases. They were subsequently followed up in the Clinical Outcomes Study (COS), and data recorded on all major illnesses since HCS, as well as current medications. Ordinal logistic regression analysed the association between early-life factors and the number of morbidities in these two surveys as well as medication count. Results: a total of 2299 participants had data in COS, 1131 (49%) were female, median age (interquartile range) at recruitment to HCS was 66 (64-68) years. Higher rates of childhood illnesses were significantly associated with future multimorbidity (multivariate odds ratio (OR) (95% confidence interval (CI)) 1.15 (1.06, 1.25)) and higher medication counts at COS (multivariate OR (95%CI) 1.14 (1.06, 1.23)). Conclusions: children who experience more illnesses at a young age may be prone to develop multi-morbidity in later life.
Background
Multi-morbidity, defined as the presence of more than one long-term condition within an individual, is increasingly prevalent and poses challenges for governments and healthcare services across the world [1] . Effective modern treatments for cardiovascular disease, cancer and other previously fatal conditions mean that people are living longer, but with a heavier chronic disease burden. Co-existent conditions can lead to reduced quality of life, limit access to therapies and operative interventions, and put patients at risk through polypharmacy [1, 2] . Much of the published literature to date has focused on measuring the prevalence or incidence of multi-morbidity in different populations, and quantifying the consequent societal costs [3] . For example, in the UK, multi-morbidity contributes significantly to the economic burden within an NHS already struggling to cope with an ageing population [4, 5] . Despite this, there is a group of individuals who remain relatively untouched by this problem, even in older age groups. Therefore, identifying factors associated with high or low multi-morbidity may be important. Lifestyle, environmental and socio-demographic factors such as education, age, smoking and obesity are recognised predictors of many common chronic conditions and contribute to the multi-morbid burden in individuals [3, 6, 7] ; in addition, there may be specific protective genes within individuals who do not develop multimorbidity. However, it is also possible that factors during the perinatal and early-childhood years contribute to the development of multi-morbidity in later life.
The aim of this study, therefore, was to investigate the association between early-life factors and future multi-morbidity in a longitudinal cohort of people in Hertfordshire, UK.
Methods

Participants and setting
The study used data from the Hertfordshire cohort study. This cohort has been described previously [8] . Briefly, all births in Hertfordshire, UK from 1931 to 1939 were reported by the attending midwife and recorded in ledgers, including details of birth weight. Subsequently, the children were visited by health visitors throughout infancy who recorded details of weight at 1 year, method of infant feeding and childhood illnesses up to the age of five in the same ledgers. Those participants who were still alive and living in Hertfordshire in 1998-2003 were traced through the NHS Central Register at Southport. With consent from their general practitioner, 6,099 of these individuals were contacted with 3,225 agreeing to a home visit during which a nurse-administered questionnaire was carried out. These participants formed the original Hertfordshire Cohort study (HCS). The questionnaire covered a wide spectrum of details about lifestyle and bone health, details of major chronic diseases, including ischaemic heart disease, cerebrovascular accidents (CVA) and diabetes. A full list of regular medications was also detailed. The same participants were contacted again in 2007-08 as part of the clinical outcomes study (COS) and 2,299 agreed to a follow-up postal questionnaire study in which participants were asked for details of hypertension, diabetes, asthma/chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, thyroid disease, vitiligo, depression, Parkinson's disease and cancer. They were also asked to provide details of any other serious illnesses since their last review in the HCS. These data were used to calculate a total multi-morbidity count at the time of the COS questionnaire
Statistical analysis
Demographic characteristics of those participants completing the COS follow-up questionnaire were compared with those not completing it. Differences in these groups were assessed using χ 2 tests for categorical variables and Student's t-tests or Mann-Whitney tests for continuous variables. Ordinal logistic regression was used to determine the association between each early-life factor and (i) the total number of multi-morbid conditions and (ii) the number of medications reported at the time of the COS questionnaire univariately. Multivariate models were then constructed adjusting for all early-life factors as well as baseline age, gender, smoking status, alcohol consumption, body mass index (BMI) and a validated measure of physical activity [9] . The models were also adjusted for time within the cohort (between HCS and COS) and year of recruitment to the HCS to account for secular changes in healthcare.
Results
The median age (interquartile range (IQR)) of the participants at recruitment to HCS was 66 (64-68) years and 1131 (49%) were female. Demographic details are shown in Table 1 . Those participants who completed the follow-up COS questionnaire (n = 2,299) were statistically significantly more likely to be female (P = 0.011), less likely to be current smokers (P < 0.001), more active (P < 0.001), had a lower BMI (P = 0.003) and were more likely to have a non-manual paternal social class (P = 0.011) than those that did not participate in COS (n = 926). There were no statistically significant differences in their age, alcohol consumption, birth weight, weight at 1 year, conditional 1 year growth, number of childhood illnesses, method of infant feeding, maternal age at birth or whether they had been immunised against diphtheria.
Four hundred and fifty-five (22%) participants reported no comorbidities with a similar number reporting three or more comorbidities (452 (22%)). The median (IQR) number of medications at COS was 4 (2-6).
Of the early-life factors, immunisation against diphtheria, paternal social class and the number of childhood illnesses were univariately associated with the multi-morbidity count at COS (Table 2) ; in the fully adjusted model only the number of childhood illnesses remained significant, odds ratio (OR) (95% confidence interval (CI)) 1.15 (1.06, 1.25), P = 0.001. Early-life predictors of future multi-morbidity
Immunisation against diphtheria and the number of childhood illnesses along with a mixed pattern of infant feeding were also associated with medication count at the time of the COS questionnaire ( Table 2 ). The number of childhood illnesses and mixed infant feeding remained significant in the fully adjusted model (OR (95%CI) 1.14 (1.06, 1.23), P < 0.001 for the number of childhood illnesses and OR (95%CI) 0.82 (0.69, 0.96), P = 0.017 for mixed infant feeding). Of the adult factors, age, BMI, physical activity and being an exsmoker were also significantly associated with both outcomes (Table 2) , whereas alcohol consumption showed no association.
Discussion
In this study, we have demonstrated that the people who experience childhood illnesses are more likely to develop multi-morbidity and have a higher medication burden later in life. This association remained significant after adjustment for socio-demographic factors in childhood (such as paternal class) and lifestyle factors later in life, such as smoking, obesity and alcohol consumption. Interestingly birth weight and infant growth were not associated with total burden of multi-morbidity, despite their known association with common chronic diseases late in life such as heart disease, COPD and diabetes which has been demonstrated within the HCS [10] [11] [12] [13] and other longitudinal studies [14, 15] . Higher rates of childhood infections (which constitute the majority of early-childhood diseases included here) have previously been associated with respiratory disease in later life and autoimmunity [11, 16, 17] ; it may be that these diseases contribute more to the overall burden of disease seen in this study. To our knowledge, this is the first study to investigate prospectively collected earlylife health factors as predictors of total burden of multimorbidity in later life. Pavela and Latham [18] investigated trajectories of multi-morbidity in the Health and Retirement study in the USA, and found that, similar to our data, poor childhood health was independently associated with increased numbers of chronic conditions. However their data on childhood economic status and childhood illness were collected retrospectively and childhood illness was assessed by a single question asking whether they could recall health under the age of 16 as good or poor. These data are, therefore, susceptible to recall bias, and it might be reasonable to suspect that adults with poorer current health might more readily recall poor health in childhood. Childhood socio-economic status (SES) has been more widely investigated as a predictor of adult health, and shown to influence burden of multi-morbidity [19] . Notably in both our study and the study by Pavela and Latham, markers of childhood SES were associated with multi-morbidity univariately, but not in multivariate models, suggesting the influence occurs *P < 0.01, **P < 0.05.
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through other factors such as later lifestyle habits or childhood illness. It should also be noted that the majority of the childhood illnesses recorded in the Hertfordshire ledgers are now vaccine preventable illnesses. Given recent resurgences in such infections [20, 21] , our data further highlight the importance of public health efforts to ensure as wide a vaccine coverage as possible.
There are limitations to this study. Not all chronic diseases were captured in the first HCS questionnaire, and data captured later in COS only pertained to illnesses occurring since the original study. Therefore, it is possible some outcomes were not captured, which may have underpowered our results, but is unlikely to have biased the results in one direction or another. Importantly, the literature around multi-morbidity suggests the impact relates primarily to common and high-impact diseases such as CVD, diabetes and depression [22] , all of which were captured in the HCS. In addition, the outcomes we used to define multi-morbidity (a multi-morbid count and number of medications) are relatively crude measures to capture a complex construct. For example, they do not take into account the severity of individual diseases and may not account for non-linear associations. Finally we were not able to include individuals who died between the two surveys (or even before they could be recruited to HCS) in our study. However, these individuals potentially had greater levels of multi-morbidity and therefore their absence will have underpowered our study. This might have contributed to the lack of association seen with birth weight and conditional growth in infancy.
In conclusion, we have demonstrated that higher rates of early-childhood illness contribute to the burden of multimorbidity later in life. This may be important for future public health policy.
Key Points
• Multi-morbidity is an increasing challenge for patients, clinicians and healthcare services.
• This is the first to study to use prospective data to investigate early-life influences on multi-morbidity.
• Higher rates of childhood illnesses before the age of 5 were associated with greater multi-morbidity in later life.
• Birth weight, conditional growth and other perinatal factors were not associated with long-term multi-morbidity in this study.
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